Patent ID: 7781212

Claim:
An antibody, or antigen binding fragment thereof, wherein the antibody comprises the complementarity determining regions (CDRs) of monoclonal antibody DMF10.34.36 and wherein the antibody is selected from the group consisting of: (i) monoclonal antibody DMF10.34.36 produced by hybridoma cell line ATCC No. PTA-404; (ii) a chimeric version of the monoclonal antibody DMF10.34.36 having light and heavy chain variable regions of the monoclonal antibody DMF10.34.36 and human light and heavy chain constant regions, wherein said chimeric version specifically binds to the antigen to which the monoclonal antibody DMF10.34.36 binds; and (iii) a humanized version of the monoclonal antibody DMF10.34.36 having the complementarity determining regions (CDRs) of the monoclonal antibody DMF10.34.36, wherein said humanized version specifically binds to the antigen to which the monoclonal antibody DMF10.34.36 binds.